Group 6 Copy 100
-1
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    What kind of microbes attach to floating plastic in coastal waters?

    While many studies have focused on the visible impact of ocean plastic, we know much less about the impact...

    Do zoonotic pathogens exist in Fijian bats and if so what are the risks of exposure to humans?

    Interactions between humans and bats can be both beneficial and detrimental. Habitat loss worldwide has increased...

    Backer Badge Funded

    A biology project funded by 47 people